Editor Profiles

Dr Ngidi currently working as CLINICAL & RADIATION ONCOLOGIST - LENMED AHMED KATHRADA PRIVATE HOSPITAL .She obtained her M.D at Masters in Medicine ( Oncology) - University of KwaZulu-Natal. She got four distinctions in matric. She then pursued her medical studies at the University of KwaZulu-Natal’s Nelson Mandela School of Medicine from 2002 to 2006. She got 10 honors and awards and she published few articles related to chemotherapy. Research interest: Research Interesting on Cancer, Oncology and Public Health

Professor, Nikolaos Andreas Chrysanthakopoulos was graduated from Dental School, University of Athens in 1998. He has also received another Degree from Faculty of Nursing from University of Athens in 1993. He was attended a program in Maxillofacial and Oral Surgery in 401 General Military Hospital of Athens during 2003-2004. He got specialist in Clinical Oncology, Cytology and Histopathology during 2013-2015. His MSc Thesis titled ‘Correlation Between Periodontal Disease Indices and Lung Cancer in Greek Adults: a Case – Control study’ consists the first in the International literature that was examined the possible association between periodontal diseases and lung cancer. Prof. Chrysanthakopoulos is a 6th year Pre-Grdt Student in Medical School, University of Athens. He is also a Professor of Human Anatomy, Human Physiology and Sports Medicine in Public Institute of Vocational Training of Patra. He has published over 47 manuscripts in International Medical and Dental Journals as unique or the 1st author, he is an Editorial Board Member in 10 International Medical and Dental Journals, Associate Editor in 1 International Medical Journal and Reviewer in 37 International Medical and Dental Journals. He has received invitations for writing Chapters in several e-Bools regarding Dental Anatomy, Oral Health and Periodontics and to participate in International Medical and Dental Congresses as a Speaker. Research Interest: Periodontology, Oral Health and Preventive Dentistry.

Dr.ALAIN L. FYMAT is a medical-physical scientist and an educator. He was educated at the University of Paris-Sorbonne and the University of California at Los Angeles. He is the current President/CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President, Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine. He was formerly Professor of Radiology, Radiological Sciences, Radiation Medicine (Oncology), Critical Care Medicine, and Physics at several U.S. and European Universities. Research interest: Dr. Fymat’s current research interests lie at the interface between science and medicine, particularly nanomedicine, nanobiotechnology, cancer/oncology, molecular/personal/precision medicine, human genetics/epigenetics/ecogenetics, neurodegenerative diseases, pharmacology and pharmacogenomics. His most recent publications deal with nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (including dementias, epilepsy, Parkinson's and Alzheimer's disease).

Dr. Aaron Lisberg is a hematologist and medical oncologist who is an Assistant Professor of Medicine at The University of California, Los Angeles. He specializes in the emerging field of immunotherapy, with a specific focus on malignancies of the lung. He is board certified in internal medicine, hematology and medical oncology. In addition to his clinical work, Dr. Lisberg conducts research on immunotherapy, and factors that might predict either a response or toxicity to immune checkpoint inhibition in lung cancer. He also conducts research on the synergistic nature of radiation and immune-based therapies. Dr. Lisberg received his medical degree from the University of Minnesota Medical School, where he was elected to the AOA honor society. He then completed his internal medicine residency at The University of Washington in Seattle, followed by his hematology/oncology fellowship at UCLA. He grew up in Minneapolis, Minnesota, and received his Bachelor of Arts degree in biology from Grinnell College. Research Interest: Immunotherapy, Oncology, Lung Cancer

Rahul Mirlekar is an immunologist with a deep and long-lasting interest in how the immune response shapes cancer and autoimmune disease. Rahul Mirlekar is leveraging the immunosuppressive populations that restrain anti-tumor immunity in pancreatic cancer and malignant melanoma, with developing new immune based therapy options for these deadly malignancies. He is acquired the knowledge, training and experience in the field of immunology to effectively carry out research in basic immunology for better translation of research findings to clinical applications. He worked on molecular mechanism of T cell differentiation associated with auto-inflammatory responses. He proposed that the regulatory T cell (Treg) function and cytokine signaling dictates the balance between Treg and Th17 cells. In addition to many first-author publications, Rahul Mirlekar have written several collaborative co-authored peer-reviewed publications in collaboration during my research studies. Currently, Rahul Mirlekar is working on cellular and molecular mechanisms of B cell-mediated immune responses during pancreatic cancer and malignant melanoma initiation and progression. Research interest: Cancer cells, Regulatory T cell (Treg) B cells

She was graduated from Toho University, School of Medicine, Tokyo, Japan at 1988. She has received PhD and MD from Nihon University School of Medicine at 1996. During 1988-1990. She was a resident in the Department of Internal Medicine Toho University, School of Medicine, Tokyo, Japan. In 1998, she was an Assistant Professor in the Department of Radiology, Nihon University School of Medicine. In 2013, she was an Assistant Professor in the Department of Pathology and Microbiology, Division of Laboratory Medicine. Nihon University School of Medicine, Tokyo, Japan. During 2014-2018, She was an Associate Professor in the Department of Pathology and Microbiology, Division of Laboratory Medicine. From 2019, she is a member of the board of Fujioka Dermatological Clinic, Tokyo, Japan. From 2016, she is an Assistant Professor, Center for General Education, Showa Women’s University, Tokyo, Japan. From October 2019, I am also an Assistant Professor, Department of Radiology, Nihon University School of Medicine, Tokyo Japan. research interest: She is a board of councilor of the Japan Society for Medical English Education, and also a board councilor of the Japan Association of Breast and Thyroid Sonology, She is a specialist in the several fields of Radiology, Ultrasound Medicine, Gastroenterology, Gastroenterological Endoscopy and Internal Medicine, She is also interested in carcinogenesis, mutagenesis, vascular medicine in atherosclerosis and dermatological imaging, especially using high-resolution ultrasonography

Minghua Wu is currently working a Professor in Laboratory of Molecular, Cellular Genetics, Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, China. She got Ph.D. from Ph.D., Major-Oncology of pathophysiology, Cancer Research Institute, Xiang-Ya School of Medicine, Central South University, Changsha, Hunan, P.R. China Research interest: Cancer Molecular, Cell Biology, Gene expression

Daniela Capdepon MD, graduate of the University F. Medical Barceló in 2001 with honors and highest academic average. Completed residency in Internal Medicine at the Municipal hospital and COBA oriented Graduate Clinical Oncology from 2002 to 2004. Then she began to study the specialty of Clinical Oncology at the University of Salvador, trained in gastric tumors in Udaondo Hospital, Hospital Marie Curie Cancer Center and Henry Moore and learned to prepare and deliver chemotherapies and concurrences to form the pallium Center for palliative treatment of pain. Graduated in the specialty of clinical oncologist and palliative medicine subspecialty in Pain in 2006 of Salvador University, Buenos Aires. Works as in Municipal Hospital and Italian Society of Zarate and Campana. Fellow in Fundaleu as subinvestigadora in Oncohematology and trained in liquid tumors, LLC, ALL MM, NHL LH. during 2006-2007. In 2008 she built her own Cancer Center and works as a medical director, in Campana Cancer Center, where cancer care is done in outpatient chemotherapy treatments and pain and palliative treatments. The cancer centre works with a specialized team with various advanced research in the field of oncology. Research interest: Tumors, Cancer, Oncology and Oncohematology